Federal Legislation
Congress Strengthens Medical Supply Chains
March 21, 2026
Congress has passed legislation amending the Defense Production Act of 1950 through H.R. 7777, known as the Protecting America’s Medical Supply Chains Act, to enhance federal authority in securing critical medical materials essential to national defense. This law modernizes provisions to bolster domestic production capabilities and ensure rapid federal response during national emergencies, emphasizing resilience in pharmaceutical and medical device supply chains.
- Why this matters: Federal agencies involved in defense and emergency preparedness will have expanded tools to prioritize and accelerate procurement of vital medical supplies.
- Procurement professionals should anticipate increased demand for domestic medical manufacturing and supply contracts aligned with national security priorities.
- Contractors specializing in pharmaceuticals, medical devices, and related materials may find new opportunities as agencies implement strengthened supply chain measures.
- Organizations should evaluate their supply chain risk management and consider alignment with federal priorities to support resilience and compliance under the updated Defense Production Act.
No nation should depend on foreign adversaries for the medicines, medical equipment, and lifesaving materials our people rely on.
— María Elvira Salazar
Agencies
House Committee on Financial Services, Federal Government
Contracts
Locations
Sources
- H.R.7777 - 119th Congress (2025-2026): To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. | Congress.gov | Library of Congress · Salazar · Mar 21
- Salazar’s Legislation Protecting America’s Medical Supply Chains Act passes Financial Services Committee | Representative Maria Salazar · Salazar · Mar 20